secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2024-09-27T23:59:59+00:00
Accession:  0001104659-24-103773
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Traws Pharma receives Nasdaq delisting notice; will request hearing to regain compliance
--------------------------------------------------------------------------------

- Received delisting determination from Nasdaq on Sept 24, 2024 for failing to maintain minimum $1 bid price.
- Second compliance period ended Sept 23, 2024; company did not regain compliance despite extension.
- Company intends to request a hearing before Nasdaq Hearings Panel by Oct 1, 2024 to stay delisting.
- Stock currently trades above $1, but no assurance of regaining compliance or meeting other listing criteria.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465924103773/0001104659-24-103773-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465924103773/tm2425081d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-103773

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer